# GLYCOPHOS
> **NDA220381** · New Drug Application · Sponsor: FRESENIUS KABI USA · Approved 2026-07-29
## Drug
- **FDA Application Number:** NDA220381
- **Application type:** New Drug Application
- **Brand name:** GLYCOPHOS
- **Generic name:** Sodium Glycerophosphate
- **Active ingredients:** SODIUM GLYCEROPHOSPHATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **First approval:** 2026-07-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220381)
---
*MORVS · CC0 1.0*